Mount Carmel's comprehensive cancer program not only provides integrated, multidisciplinary care, but also utilizes advanced technologies and cutting-edge research to prevent, detect and treat the disease. That commitment to progressive cancer care has earned us accreditation as a Network Cancer Program by the American College of Surgeons' Commission on Cancer.
As a comprehensive cancer program, we provide the means to monitor all cancers diagnosed and/or first treated here, which helps us better understand patterns, incidence, morbidity and patient survival and better evaluate the care we provide.
Mount Carmel has maintained an active cancer data center since 1955. Under the direction of the Network Cancer Committee, the Mount Carmel Cancer Data Center focuses on collecting, managing, and reporting data related to demographics, primary/metastatic sites, histologic type, grade of tumor, AJCC stage, and first course of treatment. We also do lifetime follow-up on every cancer patient diagnosed or first treated at a Mount Carmel facility so we can improve treatment planning, staging and continuity of care for all our oncology patients.
Patient confidentiality is of the utmost importance to us, which is why the Mount Carmel Cancer Data Center maintains strict confidentiality procedures and evaluates them annually. Our internal statistics are available for research studies, publications, and grant applications, and these statistics are also used to determine the feasibility of new programs and to inform our educational offerings.
More than 35,000 patients are currently included in our registry database and we're actively following more than 13,000 living patients now. That 92% follow-up rate exceeds the requirements of the American College of Surgeon's Committee on Cancer.